Transferrin

Transferrin, abbreviated Tf, is a biomarker classified under minerals. It is reported in mg/dL, allowing results to be expressed using a consistent measurement format for this marker.

Transferrin is assessed using a serum sample. Because fasting is not required for this test, it can be arranged without scheduling the collection around a fasting period. The result is reported in mg/dL and is interpreted using the reference and optimal ranges shown alongside the test result.

Transferrin results may be reviewed together with Iron Serum and Ferritin when a broader assessment is needed. These markers provide related information for interpretation, so the meaning of an individual transferrin result depends on the overall clinical context rather than the result alone. A clinician can explain how the result and related markers fit together, particularly when testing is being performed for a medical concern.

Transferrin results should be read against the reference range printed on the same laboratory report. Laboratory ranges and units can differ, so a number is meaningful only in the context of the range and units used for that report. This measurement is taken from serum, and fasting is not required.

The reference range is the broader interval used for comparison. The optimal range is a tighter interval within it, so a result may fall inside the reference range without also falling inside the optimal range. These ranges serve different purposes and should not be treated as interchangeable.

A single transferrin value is not a diagnosis and should be considered alongside the clinical context and any other relevant findings. Results outside the report’s reference range belong with a clinician for appropriate interpretation, particularly when there is a medical condition or concern.

Transferrin was measured directly in studies of Omega-3, L-Carnitine, and L-Leucine. Omega-3 left transferrin unchanged, while L-Carnitine and L-Leucine were associated with increases. These findings describe the direction of movement, not whether a change is desirable for every person.

Because transferrin is interpreted against an optimal range, an increase may move a result toward that range when the starting value is low, or farther from it when the starting value is already high. The direction therefore needs to be considered alongside the measured value and the laboratory’s reference range rather than treated as inherently beneficial or harmful.

The L-Leucine result warrants careful reading: although it is classified as an increase, the reported comparison describes a significant increase in the control group compared with the intervention group. These results concern direct measurement of transferrin, so they are more relevant to this marker than evidence about related outcomes that does not measure transferrin itself. Anyone interpreting transferrin in the context of a medical condition should review it with a clinician.